Novel therapeutic strategies in NSCLC: Lung-tumorspheres as an effective in vitro screening platform

被引：0
|
作者：
Munera Maravilla, E. [1 ]
Herreros Pomares, A. [1 ]
Calabuig-Farinas, S. [2 ,3 ]
Jantus Lewintre, E. [4 ,5 ]
Lucas, R. [6 ]
Guijarro, R. [7 ]
Martinez Madriaga, A. I. [7 ]
Blasco Cordellat, A. [8 ]
Camps, C. [5 ,9 ,10 ]
机构：
[1] Fdn Invest Hosp Gen Valencia, Lab Oncol Mol, Valencia, Spain
[2] Univ Valencia, Dept Pathol, Valencia, Spain
[3] Fdn Invest Hosp Gen Univ Valencia, Lab Oncol Mol, Valencia, Spain
[4] Univ Politecn Valencia, Dept Biotechnol, Valencia, Spain
[5] Gen Univ Hosp Res Fdn, Mol Oncol Lab, Valencia, Spain
[6] Univ Valencia, Dept Hist Ciencia, Valencia, Spain
[7] Hosp Gen Univ Valencia, Dept Thorac Surg, Valencia, Spain
[8] Hosp Gen Univ Valencia, Serv Oncol Med, Valencia, Spain
[9] Univ Valencia, Dept Med, Valencia, Spain
[10] Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 04期
关键词：
D O I：
10.1016/S1556-0864(16)30175-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62P
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [31] Osteopontin (OPN) inhibition as a novel therapeutic strategy in targeting non -small cell lung cancer (NSCLC)
    Kuo, Peiwen
    Quynh-Thu Le
    CANCER RESEARCH, 2011, 71
  • [32] Novel therapeutic strategies for rare mutations in non-small cell lung cancer
    Gou, Qitao
    Gou, Qiheng
    Gan, Xiaochuan
    Xie, Yuxin
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [33] Genomics-based screening of novel therapeutic targets and biomarkers for lung cancer.
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Development of a high throughput in vitro screening platform to identify novel inducers of immunological cell death
    Grillot, Didier
    Gangar, Akanksha
    Guillard-Huet, Raphaelle
    Boursier, Eric
    Potvain, Florent
    Serin, Guillaume
    Mirjolet, Jean-Francois
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Precision-cut lung slices as an in vitro model for testing of novel therapeutic agents
    Belamaric, Daniela
    Cedilak, Matea
    Radovanovic, Vedrana
    Banjanac, Mihailo
    Pribolsan, Lidija
    Haber, Vesna Erakovic
    Bosnar, Martina
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [36] A therapeutic screening platform for assessing antigen-specific T cell-mediated tumor killing in vitro
    Klaver, Elsenoor
    Leonard, Henry
    Lieverse, Elizabeth
    Brand, Oliver
    Reelfs, Olivier
    Kirkham, Christopher
    Schewitz-Bowers, Lauren
    Brackenbury, Louise
    CANCER RESEARCH, 2023, 84 (06)
  • [37] A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases
    Jeising, Sebastian
    Nickel, Ann-Christin
    Truebel, Johanna
    Felsberg, Joerg
    Picard, Daniel
    Leprivier, Gabriel
    Wolter, Marietta
    Huynh, My Ky
    Olivera, Marlene B.
    Kaulich, Kerstin
    Haeberle, Lena
    Esposito, Irene
    Klau, Gunnar W.
    Steinmann, Julia
    Beez, Thomas
    Rapp, Marion
    Sabel, Michael
    Dietrich, Sascha
    Remke, Marc
    Cornelius, Jan F.
    Reifenberger, Guido
    Qin, Nan
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (03) : 613 - 623
  • [38] Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
    Rawat, Pushkar Singh
    Jaiswal, Aiswarya
    Khurana, Amit
    Bhatti, Jasvinder Singh
    Navik, Umashanker
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [39] Bacterial ORF Library for Functional Genomics Screening to Discover Novel Therapeutic Strategies for Human Cancers
    Katoh, Hiroto
    Ishikawa, Shumpei
    CANCER SCIENCE, 2023, 114 : 843 - 843
  • [40] Kinesin spindle protein inhibitors in cancer: from high throughput screening to novel therapeutic strategies
    Shahin, Rand
    Aljamal, Salah
    FUTURE SCIENCE OA, 2022, 8 (03):
12345